Follow
Caitriona M. O'Driscoll
Caitriona M. O'Driscoll
Verified email at ucc.ie
Title
Cited by
Cited by
Year
Lipid-based formulations for intestinal lymphatic delivery
CM O’Driscoll
European Journal of Pharmaceutical Sciences 15 (5), 405-415, 2002
4932002
Biopharmaceutical challenges associated with drugs with low aqueous solubility—the potential impact of lipid-based formulations
CM O'driscoll, BT Griffin
Advanced drug delivery reviews 60 (6), 617-624, 2008
3592008
PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions
K Rahme, L Chen, RG Hobbs, MA Morris, C O'Driscoll, JD Holmes
Rsc Advances 3 (17), 6085-6094, 2013
3422013
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
R Hayeshi, C Hilgendorf, P Artursson, P Augustijns, B Brodin, ...
European Journal of Pharmaceutical Sciences 35 (5), 383-396, 2008
2922008
Gold nanoparticles enlighten the future of cancer theranostics
J Guo, K Rahme, Y He, LL Li, JD Holmes, CM O’Driscoll
International journal of nanomedicine, 6131-6152, 2017
2802017
Life in 3D is never flat: 3D models to optimise drug delivery
KA Fitzgerald, M Malhotra, CM Curtin, FJ O'Brien, CM O'Driscoll
Journal of Controlled Release 215, 39-54, 2015
2462015
Lipid-based nanocarriers for oral peptide delivery
Z Niu, I Conejos-Sánchez, BT Griffin, CM O’Driscoll, MJ Alonso
Advanced drug delivery reviews 106, 337-354, 2016
2442016
Pattern recognition receptors—molecular orchestrators of inflammation in inflammatory bowel disease
D Walsh, J McCarthy, C O’Driscoll, S Melgar
Cytokine & growth factor reviews 24 (2), 91-104, 2013
1862013
The blood-brain barrier in aging and neurodegeneration
EG Knox, MR Aburto, G Clarke, JF Cryan, CM O’Driscoll
Molecular psychiatry 27 (6), 2659-2673, 2022
1762022
Cell transfection with polycationic cyclodextrin vectors
SA Cryan, A Holohan, R Donohue, R Darcy, CM O’Driscoll
European journal of pharmaceutical sciences 21 (5), 625-633, 2004
1722004
Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
J Guo, L Bourre, DM Soden, GC O'Sullivan, C O'Driscoll
Biotechnology advances 29 (4), 402-417, 2011
1462011
Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate
BT Griffin, M Kuentz, M Vertzoni, ES Kostewicz, Y Fei, W Faisal, C Stillhart, ...
European Journal of Pharmaceutics and Biopharmaceutics 86 (3), 427-437, 2014
1362014
Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
ODCM Guo J., Ogier J., Desgranges S., Darcy R.
Biomaterials 33, 7775-7784, 2012
1362012
Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models
ODCM O’Neill JM, Bourre L, Melgar S
Drug Discovery Today 16 (5/6), 203-218, 2011
1362011
Therapeutic targeting in the silent era: advances in non-viral siRNA delivery
J Guo, KA Fisher, R Darcy, JF Cryan, C O’Driscoll
Molecular Biosystems 6 (7), 1143-1161, 2010
1342010
Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance
DJ Mc Carthy, M Malhotra, AM O’Mahony, JF Cryan, CM O’Driscoll
Pharmaceutical research 32, 1161-1185, 2015
1332015
Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: Focus on Huntington’s disease
BMDC Godinho, JR Ogier, R Darcy, CM O’Driscoll, JF Cryan
Molecular pharmaceutics 10 (2), 640-649, 2013
1312013
The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics
KA Fitzgerald, J Guo, EG Tierney, CM Curtin, M Malhotra, R Darcy, ...
Biomaterials 66, 53-66, 2015
1172015
Evaluation of Cellular Uptake and Gene Transfer Efficiency of Pegylated Poly-l-lysine Compacted DNA:  Implications for Cancer Gene Therapy
M Walsh, M Tangney, MJ O'neill, JO Larkin, DM Soden, SL McKenna, ...
Molecular pharmaceutics 3 (6), 644-653, 2006
1112006
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease
JC Evans, M Malhotra, JF Cryan, CM O'Driscoll
British journal of pharmacology 173 (21), 3041-3079, 2016
1022016
The system can't perform the operation now. Try again later.
Articles 1–20